Dirk Kersten joins Forbion as General Partner

Dirk is currently responsible for the life sciences investment activities at Inkef Capital as a member of its Leadership Team and Investment Committee.

As Managing Director at Inkef Capital, Dirk was closely involved in expanding Inkef’s assets under management to EUR 500M and building a team of over 15 investment professionals and seasoned industry advisors.

Prior to Inkef Capital, Dirk was a Partner at Gilde Healthcare Partners where he led a series of successful investments in biopharmaceutical and medtech companies across Europe and in the US. At Gilde, Dirk was responsible for pioneering their US investment activities and managed their Boston office for several years. Dirk holds a Master’s of Science in Physics from the University of Groningen in the Netherlands.

“We are very pleased that Dirk will be joining our team. His professional experience and contacts will be invaluable in helping us continue to invest in the most promising European life sciences companies and building new biotech companies, like Dezima Pharma, Staten Biotech and NorthSea Therapeutics”, commented Sander Slootweg, Managing Partner at Forbion.